Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Some questions about statins].

Jacques Dangoumau1, Françoise Haramburu, Bernard Bégaud

  • 1Département de Pharmacologie, Université Victor Segalen Bordeaux 2, Bordeaux, France. jacques.dangoumau@pharmaco.u-bordeaux2.fr

Therapie
|June 26, 2003
PubMed
Summary

Statins are widely used, but questions remain about their population-level impact, risk-benefit balance, and cost-effectiveness in France. Further research is needed to justify widespread statin use.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pre-existing Comorbidities as Potential Risk Modifiers for New-Onset Myocarditis and Pericarditis following mRNA COVID-19 Vaccination in Males Aged 18-30 in the United States: A Disproportionality Analysis using VAERS Spontaneous Reporting Data.

Drugs - real world outcomes·2026
Same author

The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement.

Drug safety·2024
Same author

The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration.

Drug safety·2024
Same author

What should be done to combat misinformation about health products?

Therapie·2023
Same author

Therapie·2023
Same author

Analgesic switching in chronic users of dextropropoxyphene in France.

Fundamental & clinical pharmacology·2023

Area of Science:

  • Cardiovascular Pharmacology
  • Public Health
  • Health Economics

Context:

  • Statins have been available therapeutics for over a decade.
  • Widespread statin use is being considered in large populations, such as in France.
  • Unanswered questions persist regarding their clinical application and population-level impact.

Purpose:

  • To evaluate the potential populational impact of applying clinical trial results of statins in France.
  • To critically assess the benefit-risk balance, efficacy, and cost-effectiveness of statins.
  • To determine the relevant target populations and compare statin effectiveness against other cardiovascular risk factor agents.

Summary:

  • This analysis addresses key questions surrounding statin use, including extrapolation of clinical trial data to a national context like France.
  • It examines whether the benefits of statins outweigh the risks, their effectiveness in various patient groups (including non-hypercholesterolemic), and their overall cost.
  • The study questions the efficiency and relevant target populations for statin therapy.

Impact:

  • Provides a critical evaluation to inform decisions regarding the widespread prescription of statins.
  • Highlights the need for further evidence to support the use of statins in diverse patient populations.
  • Aims to guide public health policy and clinical practice concerning statin therapeutics in France and similar healthcare systems.

Related Experiment Videos